Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant...
The Johnson and Johnson Ad26.COV2.S single dose vaccine, designed as an emergency response to the pandemic, represents an attractive option for the scale-up of COVID-19 vaccination in resource-limi...